Please note that this product was withdrawn from the Community Register of designated orphan medicinal products in July 2011 upon request of the marketing authorisation holder at the time of the granting of a marketing authorisation.
On 3 August 2007, orphan designation (EU/3/07/468) was granted by the European Commission to Sigma Tau Industrie Farmaceutiche Riunite S.p.A, Italy, for dihydroartemisinin, piperaquine for the treatment of malaria.
|Disease / condition||
Treatment of malaria
|Date of first decision||
|EU designation number||
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
- Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe;
- European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.